FORT LAUDERDALE, Fla., April 23, 2021 (GLOBE NEWSWIRE) — ECI Pharmaceuticals, LLC (ECI) today announced that it has entered into an exclusive U.S. distribution agreement with AiPing Pharmaceuticals, Inc. (AiPing) to manage the sales, marketing, and distribution of Ibuprofen 400 mg, 600 mg, 800 mg tablets, and Folic Acid 1 mg tablets. According to IQVIA…
Aiping Pharm`s Generic Benzonatate Receives Approval in US